Camptothecin compound and conjugate thereof
AssigneesMabwell (Shanghai) Bioscience Co., Ltd., Jiangsu Mabwell Health Pharmaceutical R&D Co., Ltd.
InventorsWei ZHOU, Hui XU, Huikai ZHU, Zhenzhen WANG, Xiaoding TAN
Life of this patent
Estimating the term…
Abstract
Provided is a camptothecin compound, which is a compound represented by structural formula I or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof. An antibody-drug conjugate comprising the camptothecin compound is also provided.
Claims20
A compound represented by structural formula I or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof:
- in structural formula I, R1, R2, R3, and R4 independently of one another are selected from the group consisting of hydrogen, halogen, hydroxyl, C1-6 alkoxy, amino or substituted amino, C1-7 alkyl or substituted C1-7 alkyl, or any two of R1, R2, R3, and R4, together with the carbon atoms to which they are bonded, form a C3-6 cycloalkyl;
- G is hydrogen, halogen, methyl or methoxy;
- Y is oxygen, sulfur, sulfone, sulfoxide, methylene, or substituted methylene;
- X is oxygen or sulfur;
- n=0 or 1.
A compound represented by structural formula II or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof:
- in structural formula II, R5 is C1-5 alkyl or C1-5 alkyl substituted with one or more substituents, C3-6 cycloalkyl, or C3-6 cycloalkyl substituted with one or more substituents, phenyl or substituted phenyl;
- G is hydrogen, halogen, methyl, or methoxy;
- X is oxygen or sulfur;
- n=0 or 1;
- when X is oxygen, G is hydrogen, and n=0, R5 is not n-butyl.
A compound represented by structural formula III or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof:
- in structural formula III, E is selected from the group consisting of the following groups, in which means the bonding site to M:
- M is phenylene or phenylene substituted with one or more substituents, or a chemical bond;
- and in the substituted phenylene, the phenylene is substituted with substituent(s) selected from the group consisting of alkyl, haloalkyl, alkoxy, halogen, ester, amide, and cyano;
- and preferably, M is halogen-substituted phenylene;
- SP1 is selected from the group consisting of C1-8 alkylene, C1-8 cycloalkylene, or C1-21 linear heteroalkylene comprising 1-11 heteroatoms selected from the group consisting of N, O, and S, in which the C1-8 alkylene, C1-8 cycloalkylene, and C1-21 linear heteroalkylene independently of one another are optionally substituted with one or more substituents selected from the group consisting of hydroxyl, amino, sulfonic acid group, and cyano;
- SP2 is selected from the group consisting of —NH(CH2CH2O)aCH2CH2CO—, —NH(CH2CH2O)aCH2CO—, —S(CH2)aCO—, or a chemical bond, in which a is an integer in the range of 1 to 20, preferably an integer in the range of 1 to 10, more preferably an integer in the range of 1 to 6;
- A means a peptide group of 2 to 4 amino acids;
- CPT is a compound of camptothecins.
Dependencies are inferred from the claim text.